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Abstract
Cardiovascular dysautonomia as well as the deterioration of circadian rhythms
are among the earliest detectable pathophysiological changes in individuals
with Huntington’s disease (HD). Preclinical research requires mouse models
that recapitulate disease symptoms and the Q175 knock-in model offers a
number of advantages but potential autonomic dysfunction has not been
explored. In this study, we sought to test the dual hypotheses that cardiovas-
cular dysautonomia can be detected early in disease progression in the Q175
model and that this dysfunction varies with the daily cycle. Using radioteleme-
try implants, we observed a significant reduction in the diurnal and circadian
activity rhythms in the Q175 mutants at the youngest ages. By middle age, the
autonomically driven rhythms in core body temperature were highly compro-
mised, and the Q175 mutants exhibited striking episodes of hypothermia that
increased in frequency with mutant huntingtin gene dosage. In addition, Q175
mutants showed higher resting heart rate (HR) during sleep and greatly
reduced correlation between activity and HR. HR variability was reduced in
the mutants in both time and frequency domains, providing more evidence of
autonomic dysfunction. Measurement of the baroreceptor reflex revealed that
the Q175 mutant could not appropriately increase HR in response to a phar-
macologically induced decrease in blood pressure. Echocardiograms showed
reduced ventricular mass and ejection fraction in mutant hearts. Finally, car-
diac histopathology revealed localized points of fibrosis resembling those
caused by myocardial infarction. Thus, the Q175 mouse model of HD exhibits
cardiovascular dysautonomia similar to that seen in HD patients with promi-
nent sympathetic dysfunction during the resting phase of the activity rhythm.
Introduction
Huntington’s disease (HD) patients suffer from a progres-
sive neurodegenerative process that inflicts cognitive, psy-
chiatric and motor dysfunction (Margolis and Ross 2003;
Kuljis et al. 2012a). HD is caused by a CAG repeat expan-
sion within the first exon of the Huntington (Htt) gene
which produces a polyglutamine repeat that leads to pro-
tein misfolding, soluble aggregates, and inclusion bodies
detected throughout the body (Saft et al. 2005; Ciammola
et al. 2006). The normal function of the protein (HTT) is
unknown; however, the mutated form leads to dysfunc-
tion of a large range of cellular processes including
cytoskeletal organization, protein folding, metabolism and
transcriptional activities. Cardiovascular events are a
major cause of early death in the HD population and
occur at a higher rate compared to the rest of the popula-
tion (Chiu and Alexander 1982; Lanska et al. 1988;
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Sørensen and Fenger 1992). Individuals with HD com-
monly exhibit autonomic nervous system (ANS) dysfunc-
tion that can be detected early in the disease progression
(Sharma et al. 1999; Andrich et al. 2002; Kobal et al.
2004; B€ar et al. 2008; Aziz et al. 2010) and may be
responsible for the high incidence of cardiovascular dis-
ease and early mortality due to cardiovascular events in
the HD population.
Mouse models of HD recapitulate aspects of the human
disease (Pouladi et al. 2013) including cardiovascular dys-
function. For example, ANS dysfunction has been
reported in HD models as measured by heart rate vari-
ability (HRV) and baroreceptor reflex experiments (Kudo
et al. 2011; Schroeder et al. 2011; Kiriazis et al. 2012;
Mielcarek et al. 2014). Reduced contractility and cardiac
output are also common features in HD mouse models
(Mihm et al. 2007a; Kudo et al. 2011; Schroeder et al.
2011; Wood et al. 2012; Buonincontri et al. 2014). The
cardiac-specific expression of polyQ repeats leads to car-
diovascular dysfunction, suggesting that cardiovascular
disease may be the result of cardiomyocyte abnormalities
as well as improper ANS input (Pattison et al. 2008;
Melkani et al. 2013). One of the noteworthy aspects of
the cardiovascular malfunction uncovered in previous
work is that there is a time of day influence with hyper-
tension emerging during the normal sleep time (Schroe-
der et al. 2011, 2016). This intersection between
cardiovascular symptoms and the circadian cycle needs to
be better explored in preclinical models if we are to
develop a mechanistic understanding of the neurocardio-
vascular pathology.
Among the mouse models of HD, the heterozygote
(Het) Q175 offers advantages including: a single copy of
the mutation, genetic precision of the insertion and con-
trol of mutation copy number (Bode et al. 2009; Oake-
shott et al. 2011). These features make the Het Q175 line
perhaps the most clinically relevant among the animal
models; however, possible autonomic dysfunction has not
been examined. In this study, we sought to test the dual
hypotheses that cardiovascular dysautonomia can be
detected early in disease progression in the Q175 model
and that this dysfunction varies with the daily cycle. We
used radiotelemetry to assess diurnal and circadian
rhythms in activity, core body temperature (CBT), and
heart rate (HR) in young (3–4 months of age) and mid-
dle aged (9–10 months of age) Q175 and wild-type (WT)
mice. To further explore possible autonomic dysfunction,
we measured HRV throughout the 24-h cycle as well as
the baroreceptor reflex during the normal rest cycle. In
addition, we evaluated the age-dependent progression in
heart dysfunction in a separate cohort of mice using
echocardiograms starting at 3 months of age and pro-
gressing to 12 months of age when the motor symptoms
are pronounced and brain atrophy can be detected. Tis-
sue was then collected to examine histoanatomical fea-
tures of the Q175 hearts.
Materials and Methods
Ethical approval
Homozygous (Hom) and Het Q175 mice on the C57BL6/
J background along with littermate WT controls were
acquired from the mouse-mutant resource at The Jackson
Laboratory, (JAX, Bar Harbor, Maine; stock No: 370476).
The mice are full backcrossed into the C57 line (>12
crosses) and are monitored for the number of CAG
repeats (approximately 190). Het Q175 mice commonly
live to 24 months of age but the health of the Hom Q175
declines precipitously after 16 months. Therefore, we
stopped this study well before this age point. Three sepa-
rate cohorts of mice of each genotype were used for this
study: (1) Telemetry studies measuring activity, CBT and
electrocardiograms (ECG). Recordings (6–8 weeks in
duration) were made from mice in a light-dark (LD)
cycle as well as in constant darkness (DD) starting when
the mice were 3 months and then again at 9 months of
age; (2) Baroreceptor reflex measurements at 9 months of
age; (3) longitudinal measurement of cardiac function
using echocardiograms with measurements made at 3, 6,
9 and 12 months. The hearts of this third cohort of mice
were then used for histological analysis. The LD cycle
consisted of 12 h of light and 12 h of dark. By conven-
tion, the time of lights-on being defined as zeitgeber time
zero (ZT 0). By convention, when the mice were held in
DD, the beginning of activity onset is defined at circadian
time zero (CT 0).
The health of the mice was monitored daily. We looked
for a set of symptoms including restlessness, impaired
mobility, licking or wound guarding, failure to groom,
open sores, loss of appetite or weight loss. At any sign of
ill health, a member of the veterinary staff was consulted
for course of treatment. If the animal did not improve,
then it would be humanely sacrificed with an overdose of
isoflurane followed by decapitation. For postsurgical pain
management (telemetry cohort), the mice were given
carprofen, 5 mg/kg every 24 h for 48 h minimum. The
first dose was given before surgery, and the remaining
doses postoperatively. All procedures followed guidelines
of the National Institutes of Health and were approved by
the UCLA Animal Research Committee.
Telemetry measurements
Methods employed were similar to those previously
described (Kudo et al. 2011; Schroeder et al. 2016). WT,
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Hom Q175, and Het Q175 mice (n = 10 per genotype)
were surgically implanted with a wireless radio-frequency
transmitter (ETA-F20, Data Sciences International, St.
Paul, MN). Three of the WT mice and one of the Hom
Q175 did not exhibit measureable signals and had to be
excluded from the final analysis. Mice were housed in
individual cages in the absence of a running wheel. Cages
were placed atop telemetry receivers (Data Sciences Inter-
national) in a light and temperature-controlled chamber.
Standard rodent chow was provided ad libitum. Data col-
lection began 2-weeks postsurgery, to allow mice to
recover in the 12:12 LD cycle. HR is extrapolated from
ECG waveforms using the RR interval. All measurements
were made in both LD and DD conditions at 3 months
(young) and 9 months (middle age). At each age, the
recordings took 6–8 weeks to complete. Cage activity in
DD was also examined by periodogram analysis (Clock-
Lab program, Actimetrics, Wilmette, IL) to estimate the
free-running period.
HRV
Data were extracted in 20 sec intervals then filtered to
remove extreme noise. Remaining valid data segments
were averaged into 1 h bins across the 24-h cycle. The
following parameters for time domain analysis were cal-
culated: mean normal-to-normal intervals (NN, in msec)
and, standard deviation of all NN intervals (SDNN, in
msec). For frequency domain analysis, spectra were calcu-
lated with a FFT (fast Fourier transform) with 20,000 data
points per bin and a periodogram resolution of 8192,
three overlapping subseries and a Hamming window
(HRV Module, Data Sciences International). Frequency
bins were defined as high-frequency (HF 1.5–5.0 Hz),
low-frequency (LF: 0.2–1.5 Hz) and very low frequency
(VLF: 0.01–0.2 Hz), and the power in these bands was
calculated (Campen et al. 2005; Thireau et al. 2008).
While it is common for LF and HF to be expressed in
normalized units, this normalization minimizes the circa-
dian regulation that we are interested in examining (Badi-
lini et al. 2000). Therefore, we reported the raw LF and
HF values (mV/Hz).
Baroreceptor reflex
Methods employed were similar to those described previ-
ously (Schroeder et al. 2011). The administration of
angiotensin II (ATII) or nitroprusside (NP) triggers acute
hypertension or hypotension, respectively. Changes in
blood pressure (BP) as a result of administering these
drugs should elicit a compensatory response of HR. Dif-
ferences in the ratio of change in HR to BP (ΔHR/ΔBP)
are suggestive of aberrant signaling to the heart by the
ANS. Baroreceptor function was examined during the day
(ZT4-9) in middle age (9 months) mice of each genotype:
WT (n = 8), Hom Q175 (n = 10) and Het Q175 (n = 8).
These measurements took 4 weeks to complete. The pro-
cedure was unsuccessful in some of the mice (WT, n = 1;
Het Q175, n = 2; Hom Q175, n = 1) and data could not
be used. During the experiment, HR was determined
from the R-R interval of the ECG. Mice were anesthetized
and both femoral arteries were catheterized, whereby BP
measurements were collected from one artery and drugs
were administered through the other artery. Following
catheterization, isoflurane levels were decreased to
between 1 and 1.5% and the mice were allowed to rest
for at least 10 min. Baseline BP and HR were then
recorded. AT II (4.0 lg/kg) and NP (40 lg/kg) were
administered in sequence to probe the HR response to
the changes in BP. Each treatment was followed by a
flush of saline (+heparin 3 U/mL) to ensure full delivery
of the drugs. As a control, muscarinic (75 lg/kg glycopy-
rrolate) and b-adrenergic (750 lg/kg propranolol) recep-
tors were blocked before administering another dose of
ATII or NP. The absolute value of the maximum change
in BP as well as the subsequent directional change in HR
was determined. Ratios of these two values (ΔHR/ΔBP)
reflected the magnitude HR change relative to the change
in BP that characterizes the sensitivity of the baroreceptor
response.
Echocardiograms
WT (n = 12), Q175 Het (n = 10) and Q175 Hom
(n = 10), were group housed and kept in a 12:12 LD
cycle with rodent chow provided ad libitum. Mice were
examined with echocardiograms at 3, 6, 9, 12 months of
age. After the final measurement, the mice were perfused
and morphological and histological measurements of the
heart were taken. Echocardiograms were measured using
a Siemens Acuson Sequoia C256 instrument equipped
with a 15L8 15 MHz probe (Siemens Medical Solutions,
Mountain View, CA) as previously described (Schroeder
et al. 2016). Briefly, two-dimensional, M-mode echocar-
diography and spectral Doppler images enabled measure-
ment of heart dimension and function (Left ventricle (Lv)
Mass), end-diastolic dimension (EDD), end-systolic
dimension (ESD), posterior wall thickness (PWT), ven-
tricular septal thickness (VST), ratio of the early (E) to
late (A) ventricular filling velocities (E/A ratio), fractional
shortening (FS%), and Lv Ejection Fraction (Lv EF).
Morphometry and histology
Following the longitudinal echocardiogram measure-
ments, animals were deeply anaesthetized using isoflurane
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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and perfused with phosphate-buffered saline (PBS, pH
7.4) with heparin (2 units/ml, Henry Schein, Melville,
NY) followed by 4% (w/v) paraformaldehyde (Sigma-
Aldrich) in PBS (pH 7.4). A motorized pump was used
to deliver the solutions in order to control and maintain
similar pressure between animals. Hearts were embedded
in paraffin and processed for Masson’s Trichrome stain-
ing as previously reported (Schroeder et al. 2016). Two
mid-ventricular-stained cross sections were used to obtain
morphometric measurements and to estimate the number
of fibrotic areas in WT (n = 5), Hom and Het Q175 mice
(both n = 6 per genotype). Images of the mid-ventricular
cross sections from each heart were acquired on a Zeiss
Stereomicroscope (Stemi SV 11 Apo) equipped with an
Axiocam using the AxioVision software (Carl Zeiss). Mea-
surements were performed by two observers masked to
the genotype of the mice using the Zeiss Axiovision soft-
ware. The thickness of the left ventricular wall was mea-
sured in three different nonseptal parts to obtain an
average thickness. Values from the two sections were
averaged. Fibrotic areas, suggestive of necrotic areas, that
is, infarcts, were visually identified and counted by three
observers masked to the genotype on a Zeiss Axioskop
(Carl Zeiss, Pleasanton, CA). To determine which cham-
ber or part of the interventricular septum was more
affected, the locations of the infarctions in the heart were
also annotated.
For wheat germ agglutinin (WGA) staining, deparaf-
finized sections were rehydrated through an alcohol gradi-
ent starting at 95% ethanol to 50%. Heat-induced antigen
retrieval was performed using 10 mmol/L Citrate buffer
(pH 6.0), followed by blocking in 10% BSA/PBS for 1 h.
Slides were incubated with Alexa Fluor 594-WGA (50 lg/
mL, 10 min, Invitrogen) in PBS and mounted using Pro-
Long Gold (Invitrogen, Carlsbad, CA). Confocal images
of stained sections at the levels of the papillary muscles
were captured, using a confocal scanning microscope
(Nikon, Melville, NY) and the cross-sectional area of the
cardiomyocytes was measured using the NIS Elements
(Nikon) software (50-100 cells from 6 to 8 areas per
mouse heart, n = 6 per genotype).
Statistical analysis
For most of our experiments, two-way analysis of vari-
ance (ANOVA) was used to determine statistical signifi-
cance with genotype (WT, Het Q175, Hom Q175) and
time (either ZT or CT) as the two factors. If the data did
not exhibit a normal distribution, a two-way ANOVA on
ranks was used. Post hoc t-test with Bonferroni’s correc-
tions were applied to determine significant differences
between genotypes at each of the hourly bins (ZT or CT).
In the cases in which we only obtained the measurements
at one age (baroreceptor, histological measurements), we
used a one-way ANOVA followed by Bonferroni’s multi-
ple comparison test or a one-way ANOVA on ranks. Cor-
relations between activity and heart rate were examined
by applying the Spearman correlation analysis to 21,700
contiguous, 20 sec, time-matched, heart rate and activity
bins per mouse at two ages (3 months, 9 months). R-
values were then compared between groups using a two-
way ANOVA. For a comparison of the number of
infarcts, we used a Kruskal–Wallis ANOVA followed by
Dunn’s multiple comparison test. These statistical analyses
were performed using the SigmaStat (San Jose, CA) or
Prism 5 (GraphPad Software, San Diego, CA) statistical
software. Values are reported as the mean  Standard
Error of the Mean (SEM).
Results
The aim of this study was to determine if autonomic dys-
function can be detected early in disease progression in
the Q175 model and whether the circadian cycle influ-
ences it. We used telemetry to assess Q175 rhythms in
activity, CBT and HR in young (3 months) and middle
aged (9 months) mice. All of the mice exhibited signifi-
cant day-night differences under 12:12 LD and subjective
day-night under DD conditions (Table 1). Under LD
conditions, activity was unaltered during the day but sig-
nificantly reduced throughout the night in the Hom and
Het Q175 compared to WT (Fig. 1A). These differences
in activity were also seen when the mice were held in DD
conditions, and emerged in the subjective night between
CT 13 and 23 (Fig. 1B). By middle age, there were signifi-
cant differences in the activity rhythms in LD and DD
(Table 1). Under both conditions, the Hom Q175 exhib-
ited greatly reduced activity during the night, while the
Het Q175 were not different from WT mice, except for a
reduction in activity near the end of the subjective night
(Fig. 1C, D). In each of these conditions, the amplitude
of the activity rhythms was reduced in the mutants, while
the period of the circadian rhythms did not change with
the genotype [e.g., WT = 23.86  0.05; Het
Q175 = 23.81  0.05; Hom Q175 = 23.86  0.03]. Over-
all, the Q175 mutants displayed significantly reduced
activity levels but these effects were significant only dur-
ing the night (LD) and subjective night (DD).
Next, we examined the ANS-driven rhythms in CBT in
young and middle aged mice. The young Q175 mutant
mice showed rhythms that were similar to their WT
counterparts under LD and DD conditions (Fig. 2A, B).
There was a significant effect of genotype in LD but not
DD conditions (Table 1). The young Hom Q175 did
exhibit significantly reduced body temperature late in the
night (Fig. 2A). By middle age, there were significant
2017 | Vol. 5 | Iss. 11 | e13289
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differences in the CBT rhythm in LD and DD (Table 1).
Under both conditions, the Hom Q175 exhibited diffi-
culty maintaining body temperature during the first half
of the day (subjective day) and during the late night (sub-
jective night) (Fig. 2C and D). Upon examination of CBT
with higher temporal resolution, episodes in which the
HD mutants failed to maintain their body temperature
emerged. By middle age, these hypothermic episodes were
seen in all of the Hom Q175 (8/8) and in almost half (4/
10) of the Het Q175 but were absent in WT mice. In the
Het Q175, these hypothermic events were short
(46  2 min) but, in the Hom Q175, they lasted for
more than 5 h (342  116 min). Overall, the Q175
exhibited difficulty in maintaining normal CBT and this
regulatory problem emerged early in the Hom Q175 and
was more pronounced by middle age.
In addition, we examined the HR when the animals
were physically inactive, that is, the resting HR. The
young Q175 exhibit abnormally high resting HR under
both LD and DD, mostly during the late day and early
night (Fig. 3A and B; Table 1). By middle age in DD, this
tachycardia reversed and we actually saw low resting HR
in the Hom Q175 (Table 1). The low HR in the Hom
Q175 occurred primarily during the early subjective day
(Fig. 3C and D). The simultaneous recording of HR and
activity allows the analysis of HR evoked by movement;
hence, we measured HR when the animals were physically
active, that is, the active HR. Again, a significant effect of
genotype in young animals was found under both LD
and DD (Table 1) conditions. The Hom Q175 exhibited a
significantly increased active HR during the early day and
subjective day (Table 1). Similar results were obtained in
middle aged mutants, with a significant effect of genotype
under both LD and DD (Table 1) conditions. A signifi-
cantly increased activity-evoked HR was observed in the
Hom Q175 during the early day and subjective day as
well as a reduced correlation between activity and HR
(Fig. 4). For example, in WT mice, the Spearman correla-
tion between activity and HR was 0.56  0.03 while in
the Hom Q175 the correlation was reduced to
0.42  0.02 (genotype, F = 10.4; P < 0.001). Finally, we
compared a number of parameters of the ECG waveform
(RR, PR, QRS, QT, QAT, MxdV) in WT and the Q175
mutants under LD conditions (Table 2). Significant dif-
ferences between the genotypes were seen with RR, QRS,
and QAT intervals. In summary, the Hom Q175 exhibited
tachycardia during rest and activity with the high HR
being most pronounced during the day when HR was
normally low. Even in young animals, the ANS-driven
rhythms in HR were disrupted in the Q175 line.
To further explore autonomic dysfunction in the Q175
line, we measured HRV throughout the 24-hr cycle. HRV
Table 1. Two-way ANOVA was used to determine the impact of the Q175 mutation on activity, CBT, resting HR, active HR, and HRV as mea-
sured by telemetry in LD and DD.
Young in LD Young in DD Middle age in LD Middle age in DD
Activity
Genotype F = 90.3, P < 0.001 F = 61.2, P < 0.001 F = 32.0, P < 0.001 F = 45.1, P < 0.001
Time F = 29.0, P < 0.001 F = 15.3, P < 0.001 F = 12.3, P < 0.001 F = 15.4, P < 0.001
Interaction F = 2.6, P < 0.001 F = 1.4, P = 0.06 F = 0.8, P = 0.71 F = 2.1, P < 0.001
CBT
Genotype F = 6.2, P = 0.002 F = 0.8, P = 0.75 F = 22.5, P < 0.001 F = 62.3, P < 0.001
Time F = 75.6, P < 0.001 F = 112.2, P < 0.001 F = 22.6, P < 0.001 F = 37.0, P < 0.001
Interaction F = 1.4, P = 0.03 F = 0.8, P = 0.75 F = 0.8, P = 0.85 F = 1.1, P = 0.28
Resting HR
Genotype F = 25.5, P < 0.001 F = 14.2, P < 0.001 F = 1.9, P = 0.15 F = 20.1, P < 0.001
Time F = 13.0, P < 0.001 F = 19.0, P < 0.001 F = 6.8, P < 0.001 F = 14.3, P < 0.001
Interaction F = 0.6, P = 0.98 F = 0.3, P = 1.00 F = 0.5, P = 0.99 F = 0.7, P = 0.95
Active HR
Genotype F = 3.7, P = 0.024 F = 5.1, P = 0.006 F = 13.6, P < 0.001 F = 29.2, P < 0.001
Time F = 8.6, P < 0.001 F = 5.8, P < 0.001 F = 3.5, P < 0.001 F = 7.1, P < 0.001
Interaction F = 0.7, P = 0.91 F = 0.8, P = 0.82 F = 0.9, P = 0.66 F = 1.2, P = 0.23
HRV HF power LF power
Genotype F = 92.4, P < 0.001 F = 6.8, P = 0.001 F = 41.7, P < 0.001
Time F = 7.3, P < 0.001 F = 11.7 P < 0.001 F = 9.4, P < 0.001
Interaction F = 0.5, P = 0.99 F = 0.8, P = 0.82 F = 1.3, P = 0.11
Genotype and Time were the factors.The results of a pair-wise comparison between the genotypes at each time is shown in Figure 1–4.
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measures the variability in the time between individual
heartbeats and reflects the balance of the sympathetic and
vagal inputs regulating heart rate. High HRV is associated
with cardiovascular health, while low HRV is a sign of
poor cardiovascular function. We observed high HRV
during the day and lower at night (Fig. 5A) in WT mice.
Conversely, the HRV was abnormally low in the HD
mutants (Hom, Het) and this damping was largest during
the sleep phases. HRV measures were separated into low-
frequency (LF: 0.2–1.5 Hz) and high-frequency (HF, 1.5–
5.0 Hz) bands, which are commonly used to quantify
parasympathetic and sympathetic regulation, respectively.
In WT mice, the power of both the LF and HF bands
exhibited a daily rhythm which peaked during the night
(Fig. 5B and C). The power of the HF band was mini-
mally impacted with the young Hom Q175 exhibiting sig-
nificant differences only in the late night (Fig. 5B). In
contrast, the power of the LF band was greatly impacted
throughout the night in the mutants (Fig. 5C). These
results demonstrate that the temporal patterning as well
as the overall level of autonomic regulation of the cardio-
vascular system is compromised in the Q175 mice.
The baroreceptor reflex is a rapid homeostatic mecha-
nism by which pertubations in blood pressure are coun-
tered by change in HR mediated by the ANS. We
performed baroreceptor evaluations to determine the
autonomic responsivity to drug-induced changes in BP
(Fig. 6A and B). As expected, the middle-aged WT mice
Figure 1. Q175 mice exhibited reduced amplitude of the diurnal and circadian activity rhythms as measured by telemetry starting at 3 months
of age (WT, n = 8; Het, n = 10; Hom, n = 9 for all of the telemetry measurements). All of the mice exhibited significant activity rhythms in LD
and DD conditions. The activity levels during the night were significantly altered by the Q175 mutation in the young mutants. (A) LD
conditions: activity was unaltered during the day but significantly reduced throughout the night in the Hom and Het Q175 compared to WT.
(B) DD conditions: activity was significantly reduced throughout the subjective night in the Hom and Het Q175 compared to WT. (C) By middle
age, activity was significantly reduced only in the Hom Q175. The differences in activity between Het Q175 and WT were no longer significant
as the WT mice began exhibiting the typical age-related decline. (D) In DD conditions, the middle aged Hom Q175 exhibited greatly reduced
activity during the night. Please see Table 1 for results of statistical tests. Asterisks indicate P < 0.05 between the genotypes at each of the
hourly bins (ZT or CT).
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had normal reflex responses, that is, when the BP was
transiently increased with angiotensin II (ATII, 4 lg/kg),
the heart rate dropped in compensation, and when the
BP was transiently lowered with nitroprusside (NP,
40 lg/kg), the heart rate was elevated. The effects of ATII
and NP were completely blocked by pretreatment with
sympathetic and parasympathetic receptor antagonists
(750 lg/kg propranolol, 75 lg/kg glycopyrrolate)(Fig. 6).
Interestingly, the Hom Q175 mice had very blunted HR
responses to NP (one-way ANOVA on ranks: H = 11.3,
P = 0.004). While some of the Het Q175 (2/6) showed a
greatly reduced response to the NP injection, the overall
NP-response was not significantly different from the WT
(Fig. 6A). There were no significant changes in response
to ATII injection although we did observe an abnormal
instability in the Hom Q175 HR (Fig. 6B). Systolic BP
did not significantly vary with genotype (WT:
83  4 mm Hg; Het Q175: 76  4; Hom Q175: 71  3;
F = 2.8; P = 0.08). These data provide further evidence of
diminished autonomic function, especially of the sympa-
thetic branch.
The age-dependent progression in heart dysfunction
was evaluated in a separate cohort of mice using echocar-
diograms beginning at 3 months of age and progressing
to 12 months (Fig. 7; Table 3). Both the cardiac structure
[Lv mass, EDD, ESD) and function (FS%, E/A ratio, Lv
EF) were significantly influenced by age and genotype
(Table 4). For example, the Lv mass of the Hom Q175
was significantly smaller compared to WT and Het Q175
by 6 months of age (Fig. 7A). Cardiac function, measured
by Lv EF, was significantly diminished in the Hom Q175
beginning at 9 months. Both the Hom and Het Q175
exhibited a reduction in this parameter compared to WT
at 12 months (Fig. 7B). By 9 months of age, the hearts of
Figure 2. Hom Q175 mice exhibited disrupted rhythms in CBT in middle age. (A, B) The young adult Q175 exhibited a significantly different
CBT rhythm in LD and DD conditions. Only a few phases late in the night were impacted. (C, D) By middle age, there were significant
differences in the CBT rhythm in LD and DD. The mutant mice exhibited episodes of hypothermia that were most severe in the Hom Q175.
Please see Table 1 for results of statistical tests. Asterisks indicate P < 0.05 between the genotypes at each of the hourly bins (ZT or CT).
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Hom Q175 mice were smaller and functionally depressed
compared to WTs.
We observed a significant reduction in both the body
(25%) and heart (18%) weight in the Hom Q175 as
compared to WT (Table 5). Therefore, at the end of the
echocardiogram measurements, histological analysis of the
hearts was performed to further characterize these abnor-
malities. The total area of coronal heart sections at the
mid-ventricular level in the Hom Q175 was 33% and
23% smaller than that of WT and Het Q175, respectively
(Table 5, Fig 8A). In agreement with the echocardiogram
data, the Lv lumen cross sectional area (CSA) (54%) and
circumference (23%) were greatly reduced in the Hom
Q175 (Table 5). No differences were found in the thick-
ness of the Lv wall or the interventricular septum. The
dimensions of the Het Q175 hearts were not significantly
different from WT (Table 5). Next, we measured the CSA
of individual cardiomyocytes stained with WGA (Fig. 8B).
While the WT cardiomyocytes exhibited a medium CSA
of 204  11 lm2, the CSA was 151  4 lm2 and
95  8 lm2 in the Het and Hom Q175, respectively
(ANOVA on ranks, H = 15.15, P < 0.0001). This dra-
matic reduction in size (53%) of the CSA of the car-
diomyocyte in the Hom hearts was accompanied by an
apparent disorganized cytoarchitecture of the myocar-
dium (Fig. 8B). Finally, histopathological analysis of the
heart with Masson’s trichrome stain revealed local pockets
of fibrosis where the cardiomyocytes appeared to be
replaced by scar tissue (Fig. 8C). These areas, an indica-
tion of small necrotic lesions or infarcts, were present in
the heart of all three genotypes with an average of 9.6
infarcts/section in the Hom Q175 vs 2–3 infarcts/section
in the WT and Het Q175 (Fig. 8D). Small fibrotic areas
were occasionally seen in all the WT mice examined, fre-
quently on the edge of the papillary formations in the Lv
(Fig. 8C). In the mutants, the fibrotic pockets were seen
Figure 3. Q175 mice exhibited altered diurnal and circadian resting HR rhythms. (A, B) The young Q175 exhibited significantly different resting
HR rhythms under both LD and DD. The effects were most striking under LD conditions where the mutants showed high resting HR. (C, D) By
middle age, this tachycardia reversed and we actually saw low resting HR in the Hom Q175 under DD conditions. Please see Table 1 for results
of statistical tests. Asterisks indicate P < 0.05 between the genotypes at each of the hourly bins (ZT or CT).
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in the ventricular wall of both the left and right ventricles,
some of which were extensive. Interestingly, in the Hom
Q175, these lesions were most commonly seen in the
anterior part of the interventricular septum near the ante-
rior groove, suggesting disruption of the blood supply to
the heart (Fig. 8C,D).
Discussion
In this study, we sought to test the dual hypotheses that
cardiovascular dysautonomia can be detected early in dis-
ease progression in the Q175 model and that this dys-
function varies with the daily cycle. We found
overwhelming evidence for autonomic dysfunction
including blunted daily rhythms in HR and CBT, reduced
HRV, and almost a complete failure of the sympathetic
arm of the ANS during the baroreceptor challenge.
Importantly, several aspects of the Q175 phenotype were
found to vary with a diurnal and circadian phase depen-
dence. For example, activity measurements solely during
the day would not have uncovered deficits at the young
ages and HRV deficits were more prominent during the
day but it would have been difficult to detect during the
night. Hence, the time of measurement and the circadian
cycle has to be considered as a critical factor in the
expression of HD symptoms. The Q175 mouse model of
HD exhibits cardiovascular symptoms comparable to
those seen in HD patients with a prominent sympathetic
dysfunction during the resting phase.
Q175 (Hom, Het) mice showed deficits in both diurnal
and circadian activity rhythms (Fig. 1) with the Hom
Q175 exhibiting striking deficiencies as young adult mice
(3 months). A variety of studies have now demonstrated
that four distinct mouse models of HD all exhibit a
Figure 4. Q175 mice exhibited an abnormal relationship between HR and activity. (A) The young adult Hom Q175 exhibited high HR even
while they exhibited low levels of activity. (B) By middle age, the Hom Q175 exhibited lower HR and lower activity in the night. WT data shown
with black lines (HR) and fill (activity); the Het Q175 data are shown with gray lines (HR) and fill (activity); the Hom Q175 data are shown with
red lines (HR) and fill (activity). C) Q175 homozygotes exhibited significant loss of correlation of HR with activity levels (P < 0.001) in young
mice. (D) By middle age, differences are diminished by the effects of aging and the progression of autonomic pathology in the mutants. WT
data shown with black lines (HR) and fill (activity); Het Q175 data shown with gray lines (HR) and fill (activity); Hom Q175 data shown with red
lines (HR) and fill (activity). WT, wild-type.
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progressive and rapid breakdown of the circadian rest/ac-
tivity cycle (Morton et al. 2005; Bode et al. 2009; Kudo
et al. 2011; Oakeshott et al. 2011; Loh et al. 2013).
Rhythms in locomotor activity are generated in the cen-
tral circadian clock or SCN. The circuitry by which the
SCN regulates locomotor patterns is not clearly estab-
lished but there is evidence for both neural and hormonal
SCN outputs (Li et al. 2012). At this point, we have no
evidence that degeneration in the central clock underlies
the observed behavioral disruption, although, prior work
has shown cell loss in the SCN of HD patients (van
Wamelen et al. 2013). We have previously shown that
middle-age Q175 mice show severe circadian dysfunction
with no changes in the size of the Nissl-defined SCN
(Loh et al. 2013) or in the phasing of expression of the
clock gene Period2. In agreement, here, we report no
changes in the free-running period of the circadian sys-
tem. Together this evidence makes it unlikely that the
molecular clockwork that drives circadian rhythms is
altered, but indicates that the outputs of the SCN clock
are certainly impacted. Reduced SCN neural activity was
also reported in the BACHD model (Kudo et al. 2011;
Kuljis et al. 2016). Thus, a weakening of the output from
the SCN provides the most likely explanation for the
reduced amplitude of the circadian rhythm in locomotor
activity observed in this study.
Q175 (Hom, Het) mice showed deficits in both diurnal
and circadian activity rhythms in CBT (Fig. 2) and HR
(Fig. 3) with the deficits in HR occurring in young adults
while the deficits in CBT were not observed until middle
age. The circadian rhythms in CBT and HR are indepen-
dent of locomotor activity but dependent on an intact
SCN (Ruby et al. 2002; Saleh and Winget 1977; Scheer
et al. 2005; Stephan and Nunez 1977; Warren et al. 1994;
Witte et al. 1998). The SCN projects to the dorsal subpar-
aventricular zone (Leak and Moore 2001; Deurveilher and
Semba 2003), which is necessary for driving circadian
rhythms of body temperature (Lu et al. 2001). In fact, as
reported by Refinetti et al. (1994), just a small number of
SCN neurons is sufficient to maintain circadian rhythm
in CBT. Thus, the lack of an impact on the CBT rhythm
suggests that at least some of the SCN outputs are intact
in the young Q175 mice. Young Hom Q175 exhibited
highly pronounced tachycardia during their normal sleep
time, with high HR and a reduced amplitude in the HR
rhythm (Fig. 3). In addition, the normal strong correla-
tion between activity and HR, which is mediated by the
ANS, was dramatically reduced in the mutants (Fig. 4).
These changes suggest that ANS disruption occurs early
in disease progression in the Q175 line. In agreement, we
also saw evidence in the BACHD of the circadian system
failing to lower blood pressure during sleep (Schroeder
et al. 2011). Similarly, R6/1 mice have a higher HR than
WT littermates in young but not older mutant mice
(Kiriazis et al. 2012). However, in two other models (R6/
2 and HdhQ150 lines), the HR was significantly reduced
in symptomatic mice (Mielcarek et al. 2014).
HRV is a measure of variation in the beat-to-beat
(R-R) interval that reflects the dynamic balance of sympa-
thetic and parasympathetic control of heart function. In
Table 2. Electrocardiographic parameters in young Q175 and WT animals held in a LD cycle. ECG values were continuously measured and
placed into hourly bins.
ECG parameters WT Het Q175 Hom Q175 ANOVA genotype
RR (msec) Day 124  2 121  2 115  22 F = 4.8, P = 0.019
Night 107  11 106  21 108  21 F = 0.6, P = 0.533
PR (msec) Day 36  1 34  1 35  1 F = 0.4, P = 0.698
Night 33  11 32  11 33  11 H = 0.3, P = 0.858
QRS (msec) Day 13.2  0.1 13.5  0.2 13.2  0.2 H = 3.8, P = 0.147
Night 12.8  0.11 13.1  0.21 12.6  0.11 H = 5.0, P = 0.080
QR (msec) Day 6.5  0.1 6.6  0.1 6.6  0.1 F = 0.3, P = 0.724
Night 6.3  0.11 6.4  0.11 6.3  0.11 F = 0.4, P = 0.662
QAT (msec) Day 31  6 31  5 20  12 H = 8.6, P = 0.013
Night 34  61 30  4 21  12 F = 3.9, P = 0.036
ST (msec) Day 51  3 56  3 55  3 H = 2.9, P = 0.236
Night 52  4 52  31 52  31 H = 0.2, P = 0.871
MxdV (mV/msec) Day 274  22 348  27 329  41 F = 1.4, P = 0.251
Night 348  281 411  361 394  431 F = 0.8, P = 0.468
One-way ANOVA was used to assess differences between the genotypes in the day or night. A paired t-test was used to access day/night dif-
ferences within a genotype.
1
P < 0.05 day versus night within a genotype.
2
P < 0.05 significant difference compared to WT.
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WT mice, HRV displayed a robust diurnal and circadian
rhythm consistent with circadian regulation of the ANS
(Fig. 5). Both the LF and HF domains of the HRV
exhibited robust daily rhythms. In the Q175 line, the
HRV was low in young mutants (Hom, Het) and this
reduction was largest during the rest phase (Fig. 5A). The
power in the LF domain was significantly reduced in the
young mutants with the biggest effects during the night
(Fig. 5B). Traditionally, the LF is viewed as a measure of
regulation by the sympathetic branch of the ANS,
although it is more likely a general index of ANS function
(Burr 2007; Heathers 2014). Thus, our data clearly indi-
cate that the autonomic outflow is disrupted in the HD
mutants. Autonomic dysfunction is likely responsible for
the low HRV as well as the elevated HR during the rest
Figure 5. Q175 mice exhibited low HRV as measured at 3 months.
(A) The young Q175 (Hom, Het) exhibited significantly reduced
HRV. Most phases of the daily cycle were impacted. (B) The HF
domain (1.5–5.0 Hz) was largely unaltered except at 2 phases late
in the night. (C) The LF domain (0.2–1.5 Hz) was reduced in the
mutants (Hom, Het) throughout the night. Please see Table 1 for
results of statistical tests. Asterisks indicate P < 0.05 between the
genotypes at each of the hourly bins (ZT or CT).
Figure 6. Baroreceptor evaluations were used to determine the
autonomic responsivity to blood pressure perturbations (WT, n = 7;
Het, n = 6; Hom, n = 9). As expected, the WT mice had normal
reflex responses. (A) When the blood pressure was transiently
lowered with nitroprusside (NP, 40 lg/kg), the heart rate was
elevated. (B) When the blood pressure was transiently increased
with angiotensin II (AT, 4 lg/kg), the heart rate dropped in
compensation. The impact of ATII and NP were blocked by
pretreatment with sympathetic and parasympathetic receptor
antagonists (750 lg/kg propranolol, 75 lg/kg glycopyrrolate). The
Hom Q175 mice had very blunted HR responses to NP (n = 9).
While some of the Het Q175 (2 out of 6 animals) showed a greatly
reduced response to the NP injection, the overall NP-response was
not significantly different from WT. WT, wild-type, ATII,
administration of angiotensin II.
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phase (daytime) in Q175 mice. A similar reduction in
HRV was previously observed in the BACHD line (Kudo
et al. 2011), and evidence of disrupted ANS leading to an
unstable heart beat as well as elevated levels of the sympa-
thetic transmitter (norepinephrine) were reported in the
R6/1 model (Kiriazis et al. 2012). It is also possible that
postsynaptic receptors are altered, as suggested by a recent
study showing that acetylcholine receptors (measured by
a-bungarotoxin binding) are reduced in the diaphragm of
BACHD mice (de Arag~ao et al. 2016). However, earlier
work examined cardiac b1-adrenergic receptor densities
in R6/2 and WT mice but did not see any genotypic dif-
ferences (Mihm et al. 2007a). In HD patients, a similar
decrease in HRV has also been reported during the
presymptomatic and early stages of HD progression
(Andrich et al. 2002; Kobal et al. 2004, 2010). Reduced
HRV is generally considered an indication of poor
cardiovascular health and a predictor for cardiovascular
disease and mortality (Bigger et al. 1992; Buccelletti et al.
2009; Thayer et al. 2010).
The baroreceptor reflex is also a process dependent
on autonomic function. Similar to the BACHD line
(Schroeder et al. 2011), Q175 mice showed a dramati-
cally blunted response in HR to the transient hypoten-
sion induced by NP suggesting that the sympathetic
branch has impaired homeostatic reserve (Fig. 6). The
primary deficit in the baroreceptor reflex in Q175 mice
Figure 7. The age-dependent progression in heart dysfunction was
evaluated in a separate cohort of mice using echocardiograms
starting at 3 months of age and progressing to 12 months (WT,
n = 12; Het, n = 10; Hom, n = 10). Both cardiac structural (Lv
mass, EDD, ESD) and functional (Lv % FS, E/A ratio, and Lv EF)
deficits were observed and exhibited significant effects of age and
genotype (Table 4).
Table 3. Echocardiographic parameters in Q175 and WT animals
beginning at 3 months of age.
WT Het Q175 Hom Q175
Age (months) 3 3 3
Lv mass (mg) 61  3 65  5 60  4
EDD (mm) 4.1  0.1 3.9  0.1 3.8  0.1
ESD (mm) 2.7  0.1 2.7  0.1 2.6  0.1
Ao-ET (msec) 50  1 52  2 54  2
FS (%) 35  1 33  1 32  1
E/A 1.7  0.1 1.7  0.1 1.8  0.1
Lv EF 71  1 65  1 67  2
Age (months) 6 6 6
Lv mass (mg) 72  3 74  4 57  2
EDD (mm) 4.2  0.1 4.2  0.1 3.8  0.1
ESD (mm) 2.7  0.1 2.8  0.1 2.5  0.1
Ao-ET (msec) 52  1 52  1 58  21
FS (%) 35  2 33  2 34  1
E/A 1.8  0.1 1.8  0.1 1.7  0.1
Lv EF 71  2 67  2.3 67  3
Age (months) 9 9 9
Lv mass (mg) 69  4 63  5 48  21
EDD (mm) 4.2  0.1 4.0  0.1 3.4  0.1
ESD (mm) 2.7  0.1 2.8  0.1 2.5  0.1
Ao-ET (msec) 48  1 53  1 54  21
FS (%) 36  2 28  21 27  11
E/A 1.7  0.1 1.6  0.1 1.5  0.11
Lv EF 71  2 65  3 63  11
Age (months) 12 12 12
Lv mass (mg) 68  5 61  21 39  21
EDD (mm) 4.1  0.1 3.8  0.1 3.2  0.1
ESD (mm) 2.7  0.1 2.8  0.1 2.4  0.1
Ao-ET (msec) 50  1 52  2 57  11
FS (%) 34  2 26  21 25  11
E/A 1.9  0.1 1.5  0.11 1.5  0.11
Lv EF 70  2 64  31 58  21
Two-dimensional, M-mode echocardiography and spectral Doppler
images enabled measurement of heart dimension and function
including Left ventricle mass (Lv mass), end-diastolic dimension
(EDD), end-systolic dimension (ESD), posterior wall thickness (PWT),
ventricular septal thickness (VST), aorta ejection time (Ao-ET), ratio
of the early (E) to late (A) ventricular filling velocities (E/A ratio),
fractional shortening (FS%), Lv Ejection Fraction (Lv EF).
1
P < 0.05 significant difference compared to WT.
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is unknown, as this process is mediated by various
regions of the brain including the brainstem and
hypothalamus, along with outputs from the ANS (Benar-
roch 1993; Ma et al. 2002; Kobal et al. 2004). In HD
patients, the detection of alterations in the baroreceptor
circuit, such as the vagal nuclei and cerebral cortex, have
established a possible structural cause for this dysfunc-
tion (Benarroch 1993; Andrich et al. 2002; Ma et al.
2002; B€ar et al. 2008; Kobal et al. 2010). Ideally, identifi-
cation of the site of dysfunction could be used to devise
an appropriate therapeutic approach to manage symp-
toms in HD patients. Prior studies reported HRV defi-
cits during the Valsalva maneuver, hand-grip test, and
the head up tilt test in HD patients (Aminoff and Gross
1974; Den Heijer et al. 1988; Sharma et al. 1999; B€ar
et al. 2008). Furthermore, patients complain of dizziness
and light-headedness upon standing, suggesting they suf-
fer from orthostatic hypotension due to autonomic dys-
regulation and a deficient baroreceptor reflex. (Kobal
et al. 2004; Aziz et al. 2010). The sympathetic nervous
system appears to be most impacted during the very
early stages of HD (Kobal et al. 2004, 2010; B€ar et al.
2008). As the disease advances, the parasympathetic
activity progressively decreases as well (Sharma et al.
1999; Andrich et al. 2002; B€ar et al. 2008).
As previously reported in the BACHD line as well as
other HD models (Mihm et al. 2007a; Wood et al. 2012;
Schroeder et al. 2016), the Q175 mice displayed an age-
dependent progression in heart dysfunction beginning at
presymptomatic stages (3 months). Both the structure
and function of the heart exhibited significant alterations
due to both age and genotype (Fig. 7). The mutants’
hearts were smaller and less functional by 6 months of
age (Table 3 & 5) and worsen with age. Histological anal-
ysis of the hearts also found that the mutant hearts
showed localized fibrotic lesions that resembled those
caused by myocardial infarction (Fig. 8C and D) and
imply that prior obstruction of the blood supply to the
Table 4. Two-way ANOVA was used to determine whether each of the echocardiographic parameters measured in Q175 and WT mice were
significantly different.
Lv mass (mg) EDD (mm) ESD (mm) Ao-ET (ms) FS (%) Lv EF
Genotype F = 23.1,
P < 0.001
F = 34.1,
P < 0.001
F = 6.1,
P = 0.003
F = 21.6,
P < 0.001
F = 8.6,
P < 0.001
F = 10.6,
P < 0.001
Age F = 6.4,
P < 0.001
F = 6.6,
P < 0.001
F = 0.2,
P = 0.887
F = 3.1,
P = 0.031
F = 4.5,
P = 0.005
F = 5.0,
P = 0.003
Interaction F = 3.2,
P = 0.006
F = 2.9,
P = 0.01
F = 0.5,
P = 0.780
F = 0.5,
P = 0.787
F = 1.6,
P = 0.156
F = 1.5,
P = 0.197
Genotype and age were the two factors. Measurements were made when the mice were 3, 6, 9, and 12 months of age.
Table 5. Morphological measurements in WT and Q175 mutants. were performed in heart coronal sections at the mid-ventricular level cho-
sen based on the visual presence of papillary muscles in the left ventricle (Lv).
WT Het Q175 Hom Q175 One-way ANOVA
Body Weight (g) 28  0.7 26  0.4 21  0.41 F = 64.5, P < 0.001
Heart Weight (mg) 153  4 151  1 125  21 H = 19.4, P < 0.001
Total heart cross sectional area (mm2) 31.2  1.3 27.1  1.7 20.7  0.74,6 F = 16; P = 0.0002
Circumference/perimeter (mm) 20.0  0.3 18.8  0.6 17.2  0.53 F = 7.9; P = 0.0049
Interventricular septum thickness (mm) 1.1  0.1 1.1  0.1 1.0  0.06 F = 0.6, P = 0.561
Lv thickness (mm) 1.09  0.06 1.09  0.07 1.12  0.05 F = 0.08, P = 0.917
Lv lumen cross sectional area (mm2) 8.9  1.0 6.8  0. 6 4.0  0.34,5 F = 13.7, P = 0.0005
Lv lumen circumference/perimeter (mm) 10.7  0.6 10.0  0.6 8.2  0.52 F = 5.26; P = 0.0198
Since the Lv were not perfectly round, we refer to the lumen measurements as circumference/perimeter. Values are presented as the
Mean  SEM. WT, n = 5; Het Q175, n = 6; Hom Q175, n = 6).
1
P < 0.001 versus WT.
2
P < 0.05.
3
P < 0.005.
4
P < 0.0005 versus WT.
5
P < 0.05.
6
P < 0.005 versus Het one-way ANOVA followed by Bonferroni’s multiple comparison test.
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Figure 8. Histological analyses indicated heart pathology in the Q175 mouse. (A) Representative images of Masson’s trichrome stained hearts
of each genotype showing that the gross dimensions of the Hom Q175 heart were strikingly smaller. (B) Mutants had reduced cardiomyocyte
size as well as altered cytoarchitecture as shown by WGA staining. (C) Masson’s trichrome stain revealed greatly increased incidence of fibrotic
lesions in Q175 Hom hearts. (D) These infarcts were present in each genotype, but were more common (about 3–4 folds) in both ventricles
and anteriorly in the interventricular septum of the Hom Q175. Please see Table 5 and 6 for the results of statistical tests. Data are shown as
the Mean  SEM (n = 5–6 animals/genotype). *P < 0.05. The comparison between the number of infarcts was made with Kruskal–Wallis
ANOVA followed by Dunn’s Multiple Comparison Test.
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heart caused local cell death. These fibrotic infarcted areas
are the histological signature of heart attacks.
Cardiovascular complications are a leading cause of
death in HD patients (Chiu and Alexander 1982; Lanska
et al. 1988; Sørensen and Fenger 1992; Abildtrup and
Shattock 2013). To date, several of the HD mouse models
have been shown to exhibit cardiovascular dysfunction
(Mihm et al. 2007a; Pattison et al. 2008; Kudo et al.
2011; Schroeder et al. 2011; Kiriazis et al. 2012; Wood
et al. 2012; Buonincontri et al. 2014; Mielcarek et al.
2014). Mutant Htt is expressed in both the heart and
brain (Strong et al. 1993), thus a critical question is
whether the cardiovascular pathologies seen in HD are
due to a deficit at the level of the cardiomyocytes or
whether they are secondary to central nervous system dys-
function. For example, overexpression of an expanded
polyQ track or mHtt in cardiomyocytes resulted in heart
failure and a significantly reduced lifespan in both mice
(Pattison et al. 2008) and flies (Melkani et al. 2013). So
at least some of our findings may be due to cardiomy-
ocyte-specific deficits, e.g., the changes in the ECG wave-
form in young mutant mice. In addition, in HD patients,
there is evidence of degeneration of brainstem nuclei,
including those that control the regulation of heart func-
tion (Aminoff and Gross 1974; Izzo and Taylor 1999;
Squitieri et al. 2001; B€ar et al. 2008; Kobal et al. 2010;
R€ub et al. 2014). So it is likely that there is an HD-speci-
fic cardiomyopathology as well as cardiovascular pathol-
ogy secondary to the HD-driven damage to the ANS.
Overall, this body of preclinical data suggests that moni-
toring of the cardiovascular system in HD patients should
start at an early age so therapeutic interventions can by
employed to slow the progression of these pathological
processes and prevent early death. Most importantly, our
data suggest that this early screening must include obser-
vations during the usual sleep hours of the day, as early
anomalies may go undetected at the times of day that
patients would usually interact with clinicians.
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